LINDSAY KAPLAN: Open Payments
NPI 1073166393 · BROCKTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,221 in 94 payments from 16 companies in 2025. Trend: 2023 $902 · 2024 $1,508 · 2025 $2,221
Food & beverage: $2,056Education: $165
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 27 | $644 |
| ABBVIE INC. | 19 | $418 |
| Novartis Pharmaceuticals Corporation | 14 | $330 |
| GENZYME CORPORATION | 7 | $227 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Amgen Inc. | 3 | $92 |
| UCB, Inc. | 3 | $71 |
| Galderma Laboratories, L.P. | 4 | $67 |
| STRATA Skin Sciences, Inc. | 6 | $51 |
| Organon LLC | 2 | $47 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, COSENTYX, OTEZLA, RINVOQ, LEQVIO, Bimzelx.
Industry payments across MA — which companies pay providers there.
